Author(s):
Ashvin V. Dudhrejiya, Shivangi B. Pithadiya, Amitkumar J. Vyas, Nilesh K. Patel, Ajay I. Patel, Hetal B. Gavit, Dhruvanshi A. Gol
Email(s):
shivangipithadiya1999@gmail.com
DOI:
10.52711/0974-360X.2024.00656
Address:
Ashvin V. Dudhrejiya1, Shivangi B. Pithadiya1,2*, Amitkumar J. Vyas1, Nilesh K. Patel1, Ajay I. Patel1, Hetal B. Gavit3, Dhruvanshi A. Gol1
1B. K. Mody Government Pharmacy College, Rajkot, India.
2Department of Pharmaceutical Science, Faculty of Health Sciences, Marwadi University, Gujarat, 360003, India.
3Government Pharmacy Collage, Surat, India.
*Corresponding Author
Published In:
Volume - 17,
Issue - 9,
Year - 2024
ABSTRACT:
Background: The primary objective of the present study of RP-HPLC technique by utilizing a UV detector that possesses characteristics of simplicity, sensitivity, speed, accuracy, and precision. The present study employed a methodology to concurrently determine the quantities of Mirabegron and silodosin within a synthetic blend. Material and Method: RP-HPLC Method was developed by using isocratic elution mode. Using an OROSIL C18 column that measured 150mm in length, 4.6mm in Column inside Diameter (ID), and 3µm in particle size, the materials were separated by liquid chromatography. The mobile phase employed was a blend of methanol and phosphate buffer at a 60:40% v/v ratio. And 0.5ml/min wasflowing rate, the separation was accomplished. Using a UV detector, all of the compounds were identified and measured at a wavelength of 270nm. Result: For Mirabegron and Silodosin, the linearity of the technique was seen within the range of concentration for 6.3-150 ppmand 2-48µg/ml, respectively. The range of percentage recovery for Silodosin was 98.05% to 100.23%, and for Mirabegron it was 98.86% to 100.64%. The methodology was verified in compliance with the International Council on Harmonization's criteria (Q2R1). Conclusion: The suggested RP-HPLC technique is highly appropriate for analyzing Mirabegron and Silodosin, as it guarantees precise findings without any interference.
Cite this article:
Ashvin V. Dudhrejiya, Shivangi B. Pithadiya, Amitkumar J. Vyas, Nilesh K. Patel, Ajay I. Patel, Hetal B. Gavit, Dhruvanshi A. Gol. RP-HPLC Method Development and Validation for Simultaneous Estimation of Mirabegron and Silodosin in Synthetic Mixture. Research Journal of Pharmacy and Technology. 2024; 17(9):4247-2. doi: 10.52711/0974-360X.2024.00656
Cite(Electronic):
Ashvin V. Dudhrejiya, Shivangi B. Pithadiya, Amitkumar J. Vyas, Nilesh K. Patel, Ajay I. Patel, Hetal B. Gavit, Dhruvanshi A. Gol. RP-HPLC Method Development and Validation for Simultaneous Estimation of Mirabegron and Silodosin in Synthetic Mixture. Research Journal of Pharmacy and Technology. 2024; 17(9):4247-2. doi: 10.52711/0974-360X.2024.00656 Available on: https://rjptonline.org/AbstractView.aspx?PID=2024-17-9-17
REFERENCE:
1. Sankar PR, et al. Analytical Method Development and Validation for The Determination of Mirabegron in Pharmaceutical Dosage Form By RP-HPLC. International Journal of Pharmaceutical Sciences and Research. 2020; 11(5): 2223-2228. doi: 10.13040/IJPSR.0975-8232.11(5).2223-28
2. Sarika S. Malode, Milind P. Wagh. Formulation and Evaluation of Orodispersible Tablets Containing Taste Masked Mirabegron Resinate. Research Journal of Pharmacy and Technology. 2020; 14(9): 4736-2. doi: 10.52711/0974-360X.2021.00824.
3. Rajendra K. Surawase, Kamalkishor G. Baheti. Box Behnken Design for Optimization of Mirabegron Solid Dispersion by Fluidized Bed Processing. Research Journal of Pharmacy and Technology. 2022; 15(4): 1472-6. doi: 10.52711/0974-360X.2022.00244
4. Bhamre P, Rajput SJ. Spectrofluorimetric Method For the Determination of Silodosin In Bulk And Pharmaceutical Dosage Form. Indo American Journal of Pharmaceutical Research, 4(10): 5106-5110.
5. Yoshihisa M, Shun T, et al. Comparison in the efficacy of fesoterodine or mirabegron add-on therapy to silodosin for patients with benign prostatic hyperplasia complicated by overactive bladder: A randomized, prospective trial using urodynamic studies. Wileyonlinelibrary. 2019; 33(3): 941-949. doi: 10.1002/nau.23935
6. CDSCO-Drug combination approval, August 2021, https://cdsco.gov.in/opencms/opencms/en/Approval_new/CT-Approvals/
7. Japanese Pharmacopoeia, 8th Edn, The ministry of Health, Labourand Welfare, 2017, 1573.
8. Badike KS, Nerusula A, Anne BS. Analytical method development and validation for the estimation of mirabegron in pure and its solid dosage form by UV- spectrophotometric method. International Journal of Research in Pharmaceutical sciences and Technology. 2020; 1(4): 146-150. doi: https://doi.org/10.33974/ijrpst.v1i4.207
9. Panchumarthy R, et al. Validated UV spectrophotometric method for quantitative determination of Mirabegron in bulk and Pharmaceutical dosage form. Der Pharmacia Lettre. 2016; 8(14): 96-103.
10. Aneesh TP, Rajasekaran A. Method Development And Validation For The Estimation Of Sildosin In Bulk And Pharmaceutical Dosage Forms Using Uv-vis Spectrophotometry. Asian Journal of Pharmaceutical and Clinical Research. 2012; Aug 31; 5(4): 150-2.
11. Pithadiya SB, Vyas AJ. Spectroscopic method development and validation of drug used In treatment of benign prostatic hyperplasia complicated with over active bladder. Journal of Medicinal and Nanomaterials Chemistry. 2024; 6(2): 116-125. doi: 10.48309/JMNC.2024.2.3 .
12. Fan Z, Yuxia Z, et al. Liquid Chromatographic Separation and Thermodynamic Investigation of Mirabegron Enantiomers on a Chiralpak AY-H Column. Journal of Chromatographic Science. 2015; 53: 1361–1365. doi: 10.1093/chromsci/bmv025
13. Engin Er, Nevin ErK. An effective and sensitive stability indicating chromatographic approach based on HPLC for silodosin assay. Journal of Analytical Science and Technology, 2016; 20(7): doi: 10.1186/s40543-016-0100-y.
14. Aneesh TP, Rajasekaran A. Development And Validation Of Hplc Method For The Estimation Of Silodosin In Bulk And Pharmaceutical Dosage Form. International Journal of Biological & Pharmaceutical Research. 2012; 5(4): 693-696.
15. Spandana R, Rao RN, et al. Analytical Method Development And Validation For The Estimation Of Mirabegron In Bulk And Pharmaceutical Dosage Form By RP-HPLC. Indo American Journal of Pharmaceutical Research. 2016; 11(5): 2223-2228.
16. Jyothsna M, RayeesAhmed MD, et al. Method Development and Validation of Mirabegron in Bulk Drug and Pharmaceutical Dosage Form. Journal of Pharmacy and Biological Sciences. 2018; 13(1): 78-83. doi: 10.9790/3008-1301037883
17. Suryawanshi R, Shaikh S, Patil S. RP-HPLC Method Development and Validation for the Estimation of Mirabegron in Bulk and Dosage Form. Journal of Drug Delivery & Therapeutics. 2020; 10(1): 31-38. Doi: https://doi.org/10.22270/jddt.v10i1.3829
18. Rezari M, Ramazani A. RP-HPLC Method Development and Validation for the Quantitative Estimation of Mirabegron in Extended-Release Tablets. Journal of Medicinal and Chemical Sciences, 2018; 4(4): 308-410. doi: https://doi.org/10.26655/jmchemsci.2018.9.5
19. Pigili R. Development and Validation of RPHPLC Method For Estimation of Silodosin In Bulk And Pharmaceutical Dosage Forms. International Journal of Pharmaceutical Science Review and Research. 2012; 16(2): 52-55.
20. Harischandran S, et al. Validated Stability Indicating RP-HPLC Method for the Determination of Silodosin in Pharmaceutical Dosage Form. International Journal for Pharmaceutical Research Scholars. 2012; 1(4):141-145.
21. Goud VM, et al. Method Development and Validation of RP-HPLC Method for assay of Sildosin in Pharmaceutical Dosage Form. International Journal of Pharma Sciences. 2013; 3: 194-196.
22. Gupta A, Mishra SK. A Novel Analytical Method for Simultaneous Quantification of Silodosin and Tadalafil by RPHPLC. Journal of Pharmaceutical Research International. 2021; 33(39B): 194-202. https://doi.org/10.9734/jpri/2021/v33i39B32195
23. Nataraj KS, et al. Analytical Method Development and Validation for the Estimation of Silodosin and Dutasteride in Capsule Dosage Form by RP-HPLC Method. Journal of Drug Metabolism & Toxicology. 2020; 11(2): 1-8. doi:10.35248/2157-7609.20.11.245
24. Paljashuva K, Ramarao N. Simultaneous Estimation Of Dutasteride And Silodosin In Bulk Form By Rp-hplc Method. World Journal of Current Medical and Pharmaceutical Research. 2019; oct 31; 1(5): 148-163.
25. Murugan S, Upendra Janardhan CH, Niranjan Babu M. RP-HPLC Method for Simultaneous Estimation of Albendazole and Niclosamide in Oral Suspension for Veterinary Use. Research J. Pharm. and Tech. 2016; 9(1): 27-32. doi: DOI: 10.5958/0974-360X.2016.00006.8
26. V. Agrahari, M. Bajpai, S. Nanda. Essential Concepts of Mobile Phase Selection for Reversed Phase HPLC. Research J. Pharm. and Tech. 2013; 6(5): 459-464.
27. Peethala Prathyusha, Raja Sundararajan, Palyam Bhanu, Mathrusri Annapurna Mukthinuthalapati. A new stability indicating RP-HPLC method for determination of Bilastine in bulk and pharmaceutical formulation. Research J. Pharm. and Tech. 2020; 13(6): 2849-2853. doi: 10.5958/0974-360X.2020.00507.7
28. Merugu Manasa, Vijey Aanandhi M. Stability Indicating Method Development and Validation of Semaglutide by RP-HPLC in Pharmaceutical substance and Pharmaceutical Product. Research J. Pharm. and Tech. 2021; 14(3): 1385-1389. doi: 10.5958/0974-360X.2021.00247.X
29. Baokar Shrikrishna, Ranpise Nisharani. Analytical Method Development and Validation for Simultaneous Estimation of Montelukast and Ebastine by HPLC. Research J. Pharm. and Tech. 2015; 8(1): 1-5. doi: 10.5958/0974-360X.2015.00001.3
30. Sridevi. S, Vijayakumar. R, C. N. Nalini. Method Development and Validation for the Simultaneous Estimation of Ascorbic acid, Phenylephrine HCl, Paracetamol and Levocetirizine HCl using RP-HPLC. Research J. Pharm. and Tech. 2020; 13(4): 1911-1916. doi: 10.5958/0974-360X.2020.00344.3
31. Vijaykumar T. Pawar, Shubhangi V. Pawar, Harinath N. More, Anita S. Kulkarni, Dinanath T. Gaikwad. RP-HPLC Method for Simultaneous Estimation of Cilnidipine and Chlorthalidone. Research J. Pharm. and Tech. 2017; 10(11): 3990-3996. doi: 10.5958/0974-360X.2017.00724.7
32. Sapna MR, Paresh UP. Development and Validation of RP – HPLC Method for Estimation of Lamivudine and Dolutegravir Sodium in Synthetic Mixture. Research J. Pharm. and Tech. 2019; 13(6): 2864-2868. doi: 10.5958/0974-360X.2020.00510.7
33. Thangabalan B, Salomi M, Sunitha N, Manohar Babu S. Development of validated RP-HPLC method for the estimation of Itraconazole in pure and pharmaceutical dosage form. Asian J. Pharm. Ana. 2013; 3(4): 119-123.
34. Revathi R., Saravanan V.S., Ethiraj T., Jhansi Lakshmi Marreddy. RP-HPLC Analysis for Quantitation of Candesartan Cilexetil in Solid Dosage Forms. Asian J. Pharm. Ana. 2013; 3(4): 115-118.
35. Sunitha N, Sindhura L, Thangabalan B, Manohar Babu S. Development and Validation of RP–HPLC Method for Simultaneous Estimation of Cefepime and Tazobactam in Injection Formulation. Asian J. Pharm. Ana. 2013; 3(4): 131-137.
36. Vanaja N, Preethi Ch, Manjunath SY, Krishanu Pal. Method Development and Validation for Simultaneous Estimation of Telmisartan and Chlorthalidone by RP-HPLC in Pharmaceutical Dosage Form. Asian J. Pharm. Ana. 2015; 5(4): 171-177.
37. Pawar J, Sonawane S, Chhajed S, Sanjay K. Development and Validation of RP-HPLC method for simultaneous Estimation of Metformin HCl and Gliclazide. Asian J. Pharm. Ana. 2016; 6(3): 151-154.
38. Khan H, Ali M, Ahuja A, Ali J. Validated HPLC-UV Method for Simultaneous Determination of Some Anti-Inflammatory and Analgesic Drugs. Asian J. Pharm. Ana. 2016; 6(3): 183-187.
39. Chandana OSS, Ravichandra Babu R. Stability Indicating High Performance Liquid Chromatographic Assay for the Determination of Sildenafil Tartrate. Asian J. Pharm. Ana. 2017; 7(3): 196-200.
40. Wagh K, Sonawane S, Chhajad S, Kshirsagar S. Development of a RP-HPLC method for separation of ezetimibe in presence of atorvastatin caclium and simvastatin and its application for qunatitation of tablet dosage forms. Asian J. Pharm. Ana. 2017; 7(3): 169-175.
41. Parmar A, Sonawane S, Chhajed S, Kshirsagar S. Development and validation of RP-HPLC method for simultaneous estimation of ezetimibe and glimepiride in tablet dosage form. Asian J. Pharm. Ana. 2017; 7(3): 185-188.
42. Venkateswara Rao B, Vijetha P, Vidyadhara S, Kavitha K. A Novel RP-HPLC Method Development and Validation for the Determination of Pioglitazone and Glimepiride in Bulk and Pharmaceutical Formulations. Asian J. Pharm. Ana. 2017; 7(3): 145-150.
43. Lanka RA, et al. New Rapid UPLC Method For The Estimation Of Impurities In The Capsule Dosage Form Of Silodosin. International Journal of Analytical and Bioanalytical Chemistry. 2012
44. Sayana PS, et al. Development and Validation of HPTLC Method for Quantification of Silodosin in Bulk and Pharmaceutical Dosage Form. The Pharma Innovation. 2012; 1(10).
45. Shah DA, et al. High-Performance Thin-Layer Chromatographic Method for the Estimation of Mirabegron and Solifenacin Succinate Used in the Treatment of Overactive Bladder Syndrome. Journal of planar chromatography- modern TLC. 2019; 32(4): 323-327. doi: https://doi.org/10.1556/1006.2019.32.4.7
46. Parsha S, Ravindrakumar Y, Ravichander M. LC–MS/MS and NMR Characterization of Forced Degradation Products of Mirabegron. Journal of Liquid Chromatography & Related Technologies. 2016; 39(4): 178-194. doi: https://doi.org/10.1080/10826076.2016.1144201
47. Jafer VS, Saladi S, Sait SS. Development of Stability-Indicating UHPLC Method for the Quantitative Determination of Silodosin and Its Related Substances. Journal of Chromatographic Science. 2013: 1-8. doi:10.1093/chromsci/bmt094
48. Chiguru V, et al. LC-ESI-MS/MS evaluation of forced degradation behaviour of silodosin: in vitro anti-cancer activity evaluation of silodosin and major degradation products. Journal of Pharmaceutical and Biomedical Analysis. 2017; 134: 1. doi: 10.1016/j.jpba.2016.11.013
49. ICH Harmonized Tripartite Guidelines (2005). Q2 (R1) Validation of Analytical Procedures: Text and Methodology.